Sabra Healthcare REIT, Inc. (SBRA) Receives Consensus Rating of “Hold” from Analysts
Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) have received a consensus rating of “Hold” from the nine research firms that are currently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $26.00.
A number of analysts have weighed in on SBRA shares. Zacks Investment Research cut shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Thursday, June 8th. Cantor Fitzgerald reissued a “buy” rating and set a $30.00 price objective on shares of Sabra Healthcare REIT in a report on Monday, May 8th. BidaskClub cut shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Thursday, July 13th. Jefferies Group LLC reissued a “hold” rating and set a $28.00 price objective on shares of Sabra Healthcare REIT in a report on Friday, May 12th. Finally, Mizuho reissued a “neutral” rating on shares of Sabra Healthcare REIT in a report on Wednesday, June 28th.
TRADEMARK VIOLATION WARNING: This piece was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.americanbankingnews.com/2017/08/18/sabra-healthcare-reit-inc-sbra-receives-consensus-rating-of-hold-from-analysts.html.
Sabra Healthcare REIT (SBRA) opened at 21.18 on Friday. Sabra Healthcare REIT has a 52 week low of $19.30 and a 52 week high of $29.10.
The firm also recently announced a dividend, which will be paid on Friday, August 18th. Stockholders of record on Wednesday, August 16th will be issued a $0.3599 dividend. The ex-dividend date is Monday, August 14th. Sabra Healthcare REIT’s payout ratio is 145.76%.
Institutional investors have recently made changes to their positions in the stock. BlackRock Inc. boosted its position in shares of Sabra Healthcare REIT by 9,246.7% in the first quarter. BlackRock Inc. now owns 9,293,011 shares of the real estate investment trust’s stock worth $259,556,000 after buying an additional 9,193,585 shares during the last quarter. Numeric Investors LLC acquired a new position in shares of Sabra Healthcare REIT during the second quarter worth approximately $30,450,000. APG Asset Management US Inc. acquired a new position in shares of Sabra Healthcare REIT during the second quarter worth approximately $26,582,000. LSV Asset Management boosted its position in shares of Sabra Healthcare REIT by 45.5% in the first quarter. LSV Asset Management now owns 2,778,914 shares of the real estate investment trust’s stock worth $77,615,000 after buying an additional 868,441 shares during the last quarter. Finally, Vanguard Group Inc. boosted its position in shares of Sabra Healthcare REIT by 6.4% in the second quarter. Vanguard Group Inc. now owns 13,229,559 shares of the real estate investment trust’s stock worth $318,832,000 after buying an additional 797,491 shares during the last quarter. 99.26% of the stock is currently owned by institutional investors and hedge funds.
About Sabra Healthcare REIT
Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.
Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.